Bristol Myers Squibb reported $45.16B in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
ALKERMES ALKS:US $ 297.07M 0.63M
Amgen AMGN:US $ 32782M 97M
AstraZeneca AZN:LN 27495M 7363M
Astrazeneca AZN:US $ 27495M 7363M
Biogen BIIB:US $ 7269.2M 2M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Catalent CTLT:US $ 3241M 17.8M
Coherus Biosciences CHRS:US $ 406.09M 0.44M
Drreddys Laboratories RDY:US $ 33373M 3065M
Eli Lilly And LLY:US $ 16515.1M 310.6M
Endo International Ordinary Shares ENDP:US $ 8304.11M 3.58M
GlaxoSmithKline GSK:LN 25483M 736M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Horizon Pharma HZNP:US $ 2576.44M 2.07M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
JAZZ PHA JAZZ:US $ 6744.3M 4642.65M
Lannett LCI:US $ 590.68M 20.02M
Medtronic MDT:US $ 25964M 425M
Novartis NOVN:VX SF 35769M 2030M
Perrigo Ordinary Shares PRGO:US $ 3555.9M 5.2M
Phibro Animal Health PAHC:US $ 392.08M 11.86M
Prestige Brands PBH:US $ 1554.12M 65.06M
Regeneron Pharmaceuticals REGN:US $ 2697.6M 0.9M
Revance Therapeutics RVNC:US $ 280M 0.31M
Teva Pharmaceutical Industries TEVA:US $ 25132M 147M
United Therapeutics UTHR:US $ 800M 0M
Zoetis ZTS:US $ 7196M 5M